1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018) Authors: Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; Rook, Alain H; Porcu, Pierluigi; Horwitz, Steven M; Whittaker, Sean; Tokura, Yoshiki; Vermeer, Maarten; Zinzani, Pier Luigi; Sokol, Lubomir; Morris, Stephen; Kim, Ellen J; Ortiz-Romero, Pablo L; Eradat, Herbert; Scarisbrick, Julia; Tsianakas, Ath... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗